Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
07/1991
07/07/1991WO1991010654A1 Muscarinic receptor antagonists
07/05/1991WO1991009614A1 GPIbα FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS
07/05/1991CA2072753A1 Gpi.beta.o fragments and recombinant dna expression vectors
07/04/1991WO1991009573A1 Preparation of fibrinogen/factor xiii precipitate
07/04/1991CA2072371A1 Preparation of fibrinogen/factor xiii precipitate
07/03/1991EP0435085A1 Phenoxyalkylcarboxylic amides, process for their preparation and drug containing them
07/03/1991EP0434832A1 D8- and D9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE.
07/03/1991CN1052667A 唑衍生物  derivatives
07/03/1991CN1052664A Antithrombotic compounds
07/02/1991US5028733 Prostaglandins
07/02/1991US5028603 Platelet-Activating Factor Antagonist; Useful In Treatment Of Inflammatory Diseases, Allergic Diseases, Asthma, Respiratory System Disorders
07/02/1991US5028588 Blood substitutes
07/02/1991US5028411 Pharmaceutical compositions
07/02/1991CA1285570C 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
07/02/1991CA1285569C 7-oxabicycloheptane substituted amide-thioamide prostalglandin analogs
07/02/1991CA1285480C Plasma exchange composition
06/1991
06/30/1991WO1991010142A1 Determining the diuretic potency of candidate drugs
06/30/1991WO1991009960A1 Hybrid protein c
06/30/1991WO1991009857A1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications
06/30/1991CA2072564A1 Determining the diuretic potency of candidate drugs
06/27/1991WO1991009124A1 Variants of pai-2
06/27/1991WO1991009122A1 A recombinant human factor viii derivative
06/27/1991WO1991008765A1 Stabilization of k2p pro
06/27/1991DE3942145A1 T-pa-solubilisierung T-pa-solubilization
06/27/1991DE3942143A1 T-pa pro stabilisierung T-pa per stabilization
06/27/1991DE3942142A1 Stabilisierung von glykosyliertem t-pa Stabilization of glycosylated t-pa
06/27/1991DE3942141A1 K2p pro-stabilisierung K2p pro-stabilization
06/26/1991EP0434057A2 Indolocarbazole derivatives, processes for their preparation and their use
06/26/1991EP0434034A1 Oxazole derivatives
06/26/1991EP0433275A1 Composition based on heparin micropolysaccharides, active when administered orally.
06/25/1991US5026855 Stereospecific process for the preparation of furo[3,4-c]pyridine, enantiomer, compounds thus obtained and therapeutical compositions thereof
06/25/1991US5026826 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
06/25/1991US5026705 Benzimidazolylpyridazinones
06/24/1991CA2032570A1 Phenoxyalkylcarboxylic acid amides, processes for the prepa ration thereof and pharmaceutical compositions containing them
06/21/1991WO1991008767A1 STABILIZATION OF GLYCOSYLIZED t-PA
06/21/1991WO1991008766A1 STABILIZATION OF t-PA pro
06/21/1991WO1991008764A1 SOLUBILIZATION OF t-PA
06/21/1991CA2046876A1 Stabilisation of glycosated t-pa
06/21/1991CA2032674A1 Oxazole derivatives
06/19/1991WO1991008752A1 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
06/19/1991EP0432537A2 Supersulfated heparins
06/18/1991US5025034 Prostaglandins
06/13/1991WO1991008297A1 Methods and materials for expression of human plasminogen variant
06/13/1991WO1991008229A1 Hirudine polyalkylene glycol conjugates
06/13/1991WO1991007988A1 Megakaryocyte production
06/12/1991WO1991009024A1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
06/12/1991EP0432134A1 Hybridoma cell lines and monoclonal antibodies
06/12/1991EP0431811A1 Thrombolytic agents
06/12/1991EP0431735A1 Improvement in diuresis by cyclodextrins and their derivatives
06/12/1991EP0431113A1 Atrial peptide derivatives
06/12/1991EP0431074A1 Disinfecting blood constituents, corneal and scleral tissue
06/12/1991EP0263138B1 Improvements in or relating to the treatment of sickle cell disease
06/12/1991EP0233908B1 Collagen-specific enzyme with platelet aggregation inhibition properties
06/12/1991CN1052112A Process for preparing naphthyl oxazolididone derivatives
06/12/1991CA2046603A1 Quinazoline-3-alkanoic acid derivatives, their salts and their preparation processes
06/11/1991US5023273 6-oxoprostaglandin E derivatives, process for their production and their pharmaceutical use
06/11/1991US5023268 Therapy for cerebral edema
06/11/1991US5023236 Factor VII/VIIA active site inhibitors
06/11/1991US5023233 Fibrinogen receptor antagonists
06/08/1991WO1991009125A1 Proteins and nucleic acids
06/08/1991WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins
06/08/1991CA2069105A1 Proteins and nucleic acids
06/05/1991EP0430800A1 Substituted benzothiazolinones, process for their preparation and pharmaceutical compositions containing them
06/05/1991EP0430637A1 Fibrinolytic protein and production method thereof
06/05/1991EP0430459A1 Tetrahydronaphthalene derivatives and preparation thereof
06/05/1991EP0429537A1 Atrial natriuretic peptide clearance inhibitors
06/05/1991EP0429480A1 Natriuretic hormone
06/05/1991CN1051937A Stem cell factor
06/05/1991CN1051936A Drythropoietin isoforms
06/04/1991US5021561 Complexes of iron or other metals with sulphonated derivatives of chitosan
06/04/1991US5021448 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
06/04/1991US5021445 Hyperglycemic and hypertensive agents; anticoagulants, alpha2-adrenoceptor antagonists
06/04/1991US5021444 Anticoagulants
06/04/1991US5021440 Imidazole compounds and their use as transglutaminase inhibitors
06/04/1991US5021430 Certain N-substituted butyramide derivatives
06/04/1991US5021417 Use of a folinic acid substance as a platelet aggregation inhibitor
06/04/1991CA1284654C ¬4.2.0|bicyclooctane derivatives with valuable therapeutic properties
06/04/1991CA1284644C 7-oxabicycloheptane substituted keto-amide prostaglandin analogs
06/04/1991CA1284643C 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs
06/04/1991CA1284642C Prostacyclin (pgi ) analogues
06/02/1991WO1991007977A1 Peptides and antibodies that inhibit integrin-ligand binding
06/02/1991WO1991007976A1 Anti-thrombotic peptides and pseudopeptides
06/02/1991CA2069902A1 Peptides and antibodies that inhibit integrin-ligand binding
06/02/1991CA2069754A1 Anti-thrombotic peptides and pseudopeptides
06/02/1991CA2031233A1 Megakaryocyte production
05/1991
05/30/1991WO1991007495A1 A mammalian cytokine, il-11
05/30/1991WO1991007484A1 Protein having activity like that of human protein c and/or activated human protein c
05/30/1991WO1991007429A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety
05/30/1991WO1991007183A1 Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical compositions incorporating same
05/30/1991CA2069448A1 Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical compositions incorporating same
05/30/1991CA2031027A1 Substituted benzothiazolinones, preparation process thereof and pharmaceutical compositions containing the same
05/29/1991EP0428860A2 Substituted (quinolin-2-yl-methoxy)phenyl-carbonyl-ureas
05/29/1991EP0428854A2 Process for the preparation of 4-(4-isobutylphenyl)-butyraldehyde
05/29/1991EP0428585A1 Novel method of administering aspirin and dosage forms containing same
05/29/1991CN1051732A Method for isolating biologically active compounds
05/28/1991US5019588 1-oxaspiro[4,5] decane-7,8-diaminoarylamides
05/28/1991US5019587 Anticoagulants
05/28/1991US5019581 5-substituted (4,5-c) imidazopyridine compounds which have useful platelet activating factor antagonistic activity
05/28/1991US5019576 Anticoagulants
05/28/1991CA2030927A1 Fibrinolytic protein and production method thereof
1 ... 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 ... 671